Literature DB >> 23406372

Structural and functional analysis of the pro-domain of human cathelicidin, LL-37.

Marzena Pazgier1, Bryan Ericksen, Minhua Ling, Eric Toth, Jishu Shi, Xiangdong Li, Amy Galliher-Beckley, Liqiong Lan, Guozhang Zou, Changyou Zhan, Weirong Yuan, Edwin Pozharski, Wuyuan Lu.   

Abstract

Cathelicidins form a family of small host defense peptides distinct from another class of cationic antimicrobial peptides, the defensins. They are expressed as large precursor molecules with a highly conserved pro-domain known as the cathelin-like domain (CLD). CLDs have high degrees of sequence homology to cathelin, a protein isolated from pig leukocytes and belonging to the cystatin family of cysteine protease inhibitors. In this report, we describe for the first time the X-ray crystal structure of the human CLD (hCLD) of the sole human cathelicidin, LL-37. The structure of the hCLD, determined at 1.93 Å resolution, shows the cystatin-like fold and is highly similar to the structure of the CLD of the pig cathelicidin, protegrin-3. We assayed the in vitro antibacterial activities of the hCLD, LL-37, and the precursor form, pro-cathelicidin (also known as hCAP18), and we found that the unprocessed protein inhibited the growth of Gram-negative bacteria with efficiencies comparable to that of the mature peptide, LL-37. In addition, the antibacterial activity of LL-37 was not inhibited by the hCLD intermolecularly, because exogenously added hCLD had no effect on the bactericidal activity of the mature peptide. The hCLD itself lacked antimicrobial function and did not inhibit the cysteine protease, cathepsin L. Our results contrast with previous reports of hCLD activity. A comparative structural analysis between the hCLD and the cysteine protease inhibitor stefin A showed why the hCLD is unable to function as an inhibitor of cysteine proteases. In this respect, the cystatin scaffold represents an ancestral structural platform from which proteins evolved divergently, with some losing inhibitory functions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406372      PMCID: PMC3634326          DOI: 10.1021/bi301008r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  91 in total

1.  The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa.

Authors:  J Malm; O Sørensen; T Persson; M Frohm-Nilsson; B Johansson; A Bjartell; H Lilja; M Ståhle-Bäckdahl; N Borregaard; A Egesten
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma.

Authors:  O Sørensen; T Bratt; A H Johnsen; M T Madsen; N Borregaard
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

3.  The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations.

Authors:  B Agerberth; J Charo; J Werr; B Olsson; F Idali; L Lindbom; R Kiessling; H Jörnvall; H Wigzell; G H Gudmundsson
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

Review 4.  Structural features and biological activities of the cathelicidin-derived antimicrobial peptides.

Authors:  R Gennaro; M Zanetti
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

Review 5.  Structure and biology of cathelicidins.

Authors:  M Zanetti; R Gennaro; M Scocchi; B Skerlavaj
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

6.  The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6.

Authors:  M Frohm Nilsson; B Sandstedt; O Sørensen; G Weber; N Borregaard; M Ståhle-Bäckdahl
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

7.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.

Authors:  C L Wilson; A J Ouellette; D P Satchell; T Ayabe; Y S López-Boado; J L Stratman; S J Hultgren; L M Matrisian; W C Parks
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

8.  Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds.

Authors:  A M Cole; J Shi; A Ceccarelli; Y H Kim; A Park; T Ganz
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

9.  Bactericidal activity of mammalian cathelicidin-derived peptides.

Authors:  S M Travis; N N Anderson; W R Forsyth; C Espiritu; B D Conway; E P Greenberg; P B McCray; R I Lehrer; M J Welsh; B F Tack
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

10.  LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

Authors:  Q Chen; A P Schmidt; G M Anderson; J M Wang; J Wooters; J J Oppenheim; O Chertov
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  8 in total

1.  Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation.

Authors:  Francesc Puig-Basagoiti; Takasuke Fukuhara; Tomokazu Tamura; Chikako Ono; Kentaro Uemura; Yukako Kawachi; Satomi Yamamoto; Hiroyuki Mori; Takeshi Kurihara; Toru Okamoto; Hideki Aizaki; Yoshiharu Matsuura
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

2.  Safety, efficacy and utility of methods of transferring adhesive and cohesive Escherichia coli cells to microplates to avoid aerosols.

Authors:  Bryan Ericksen
Journal:  F1000Res       Date:  2014-11-06

3.  Effect of recombinant prophenin 2 on the integrity and viability of Trichomonas vaginalis.

Authors:  J L Hernandez-Flores; M C Rodriguez; A Gastelum Arellanez; A Alvarez-Morales; E E Avila
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

4.  Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs.

Authors:  Susu M Zughaier; Pavel Svoboda; Jan Pohl
Journal:  Antibiotics (Basel)       Date:  2014-12

5.  High-Throughput Quantification of Bacterial-Cell Interactions Using Virtual Colony Counts.

Authors:  Stefanie Hoffmann; Steffi Walter; Anne-Kathrin Blume; Stephan Fuchs; Christiane Schmidt; Annemarie Scholz; Roman G Gerlach
Journal:  Front Cell Infect Microbiol       Date:  2018-02-15       Impact factor: 5.293

6.  Physicochemical-guided design of cathelicidin-derived peptides generates membrane active variants with therapeutic potential.

Authors:  Nelson G J Oliveira; Marlon H Cardoso; Nadya Velikova; Marcel Giesbers; Jerry M Wells; Taia M B Rezende; Renko de Vries; Octávio L Franco
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

Review 7.  Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy.

Authors:  Fatai Lu; Yingkang Zhu; Guodong Zhang; Zunpeng Liu
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

8.  An acidic model pro-peptide affects the secondary structure, membrane interactions and antimicrobial activity of a crotalicidin fragment.

Authors:  Nelson G O Júnior; Marlon H Cardoso; Elizabete S Cândido; Daniëlle van den Broek; Niek de Lange; Nadya Velikova; J Mieke Kleijn; Jerry M Wells; Taia M B Rezende; Octávio Luiz Franco; Renko de Vries
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.